
Phase 2 data show RAP-219 eases acute bipolar mania with significant YMRS gains and encouraging tolerability, setting the stage for FDA talks and phase 3 plans.
The bipolar diagnosis introduces some unique aspects to violence prevention and management, although the general principles are similar to those for patients with other psychiatric disorders. More in this slideshow.
 Related content:For more on this topic please see “Violence in Bipolar Disorder,” by Allison M. R. Lee, MD and Igor I. Galynker, MD, PhD, on which this slideshow is based.
